Daniele Pastori


Titolo Pubblicato in Anno
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients THROMBOSIS AND HAEMOSTASIS 2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study THROMBOSIS RESEARCH 2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis THROMBOSIS AND HAEMOSTASIS 2022
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome” JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review NUTRIENTS 2022
A Meta-Analysis of Plasma Homocysteine in Buerger's Disease THROMBOSIS AND HAEMOSTASIS 2022
Thrombotic aspects of SARS-CoV-2 infection: indications for treatment ITALIAN JOURNAL OF EMERGENCY MEDICINE 2022
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study ANTIOXIDANTS 2022
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease NUTRIENTS 2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease BIOMEDICINES 2022
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry PLATELETS 2022
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry JOURNAL OF PERSONALIZED MEDICINE 2022
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department INTERNAL AND EMERGENCY MEDICINE 2022
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. the multicenter ATHERO-APS study JOURNAL OF AUTOIMMUNITY 2022
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices EUROPACE 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study THE LANCET 2022
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review) CURRENT MEDICINAL CHEMISTRY 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Intima media thickness of carotid arteries in familial Mediterranean fever: a systematic review and meta-analysis CLINICAL RHEUMATOLOGY 2022


  • LS4
  • LS4_10
  • LS7
  • LS7_10


cardiovascular disease
Novel oral anticoagulants
atrial fibrillation
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma